BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16150648)

  • 21. Efficient transduction of neurons using Ross River glycoprotein-pseudotyped lentiviral vectors.
    Jakobsson J; Nielsen TT; Staflin K; Georgievska B; Lundberg C
    Gene Ther; 2006 Jun; 13(12):966-73. PubMed ID: 16511527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional HIV-2- and SIVsmmPBj- derived lentiviral vectors generated by a novel polymerase chain reaction-based approach.
    Kloke BP; Schüle S; Mühlebach MD; Wolfrum N; Cichutek K; Schweizer M
    J Gene Med; 2010 May; 12(5):446-52. PubMed ID: 20440755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. G2 cell cycle arrest and cyclophilin A in lentiviral gene transfer.
    Zhang S; Joseph G; Pollok K; Berthoux L; Sastry L; Luban J; Cornetta K
    Mol Ther; 2006 Oct; 14(4):546-54. PubMed ID: 16901758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Construction of a lentiviral vector for RNA interference of PRL-3 gene and its stable expression in SW480 cells].
    Liu YH; Li JM; Zhou J; Ding YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):509-12. PubMed ID: 18495578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lentiviral vector gene transfer into human T cells.
    Verhoeyen E; Costa C; Cosset FL
    Methods Mol Biol; 2009; 506():97-114. PubMed ID: 19110622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversible immortalization of human primary cells by lentivector-mediated transfer of specific genes.
    Salmon P; Oberholzer J; Occhiodoro T; Morel P; Lou J; Trono D
    Mol Ther; 2000 Oct; 2(4):404-14. PubMed ID: 11020357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient lentiviral transduction of Herpesvirus saimiri immortalized T cells as a model for gene therapy in primary immunodeficiencies.
    Toscano MG; Frecha C; Ortega C; Santamaría M; Martín F; Molina IJ
    Gene Ther; 2004 Jun; 11(12):956-61. PubMed ID: 15029233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shuttle of lentiviral vectors via transplanted cells in vivo.
    Blömer U; Gruh I; Witschel H; Haverich A; Martin U
    Gene Ther; 2005 Jan; 12(1):67-74. PubMed ID: 15385952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [*OPCML gene transferred by recombinant lentiviruses in vitro and its inhibition to ovarian cancer cells].
    Yao DS; Li L; Garson K; Vanderhyden BC
    Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):333-8. PubMed ID: 16762191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
    Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
    Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.
    Reuss S; Biese P; Cosset FL; Takeuchi Y; Uckert W
    Gene Ther; 2007 Apr; 14(7):595-603. PubMed ID: 17235289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene transfer systems derived from Visna virus: analysis of virus production and infectivity.
    Berkowitz RD; Ilves H; Plavec I; Veres G
    Virology; 2001 Jan; 279(1):116-29. PubMed ID: 11145895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spleen necrosis virus-derived C-type retroviral vectors for gene transfer to quiescent cells.
    Parveen Z; Krupetsky A; Engelstädter M; Cichutek K; Pomerantz RJ; Dornburg R
    Nat Biotechnol; 2000 Jun; 18(6):623-9. PubMed ID: 10835599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient gene expression by nonintegrating lentiviral vectors.
    Nightingale SJ; Hollis RP; Pepper KA; Petersen D; Yu XJ; Yang C; Bahner I; Kohn DB
    Mol Ther; 2006 Jun; 13(6):1121-32. PubMed ID: 16556511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes.
    Thaler S; Schnierle BS
    Mol Ther; 2001 Sep; 4(3):273-9. PubMed ID: 11545619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lentiviral vector-mediated siRNA knockdown of SR-PSOX inhibits foam cell formation in vitro.
    Zhang L; Liu HJ; Li TJ; Yang Y; Guo XL; Wu MC; Rui YC; Wei LX
    Acta Pharmacol Sin; 2008 Jul; 29(7):847-52. PubMed ID: 18565283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA transposons for modification of human primary T lymphocytes.
    Huang X; Wilber A; McIvor RS; Zhou X
    Methods Mol Biol; 2009; 506():115-26. PubMed ID: 19110623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safe two-plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one-step protocol.
    Lu X; Humeau L; Slepushkin V; Binder G; Yu Q; Slepushkina T; Chen Z; Merling R; Davis B; Chang YN; Dropulic B
    J Gene Med; 2004 Sep; 6(9):963-73. PubMed ID: 15352069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene delivery into primary cerebral cortical neurons by lentiviral vector.
    Zhang Y; Wang H; Pan H; Bao X; Li M; Jin J; Wu X
    Cell Biol Int; 2006 Oct; 30(10):777-83. PubMed ID: 16872845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene therapy in skin: choosing the optimal viral vector.
    Teo EH; Cross KJ; Bomsztyk ED; Lyden DC; Spector JA
    Ann Plast Surg; 2009 May; 62(5):576-80. PubMed ID: 19387165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.